Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
shares in Millions, $ in Millions
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 3,561 $ 4,835
Short-term investments 2,224 1,020
Accounts receivable, net 5,054 4,126
Inventories 4,445 3,771
Receivables from related parties 1  
Prepaid expenses and other current assets 1,403 1,265
Total current assets 16,688 15,019
Property and equipment, net 1,566 1,513
Operating lease right-of-use assets 507 460
Goodwill 24,186 24,177
Intangible Assets, Net (Excluding Goodwill) 21,950 24,118
Investment: equity method 93 83
Deferred tax assets 76 58
Other non-current assets 2,560 2,152
Total assets 67,626 67,580
Current liabilities:    
Accounts payable 2,245 2,493
Accounts Payable, Other 325 463
Accrued liabilities 3,376 3,077
Other current liabilities 929 336
Less: current portion of long-term debt (principal amount) 752 0
Total current liabilities 7,627 6,369
Long-term debt 1,715 2,467
Long-term operating lease liabilities 395 396
Deferred tax liabiilty 1,152 1,934
Other long-term liabilities 1,767 1,664
Commitments and contingencies (See Note 12)
Capital stock:    
Common stock, par value $0.01; shares authorized: 2,250; shares issued: 1,660 and 1,645; shares outstanding: 1,615 and 1,612 17 16
Additional paid-in capital 59,182 58,005
Treasury stock, at cost (shares held: 45 and 33) (4,235) (3,099)
Retained earnings (Accumulated deficit) 56 (131)
Accumulated other comprehensive loss (50) (41)
Total stockholders’ equity 54,970 54,750
Total liabilities and stockholders’ equity $ 67,626 $ 67,580
Common stock, outstanding (in shares) 1,615 1,612
Common stock, par value (in dollars per share) $ 0.01  
Common stock, authorized (in shares) 2,250  
Common stock, issued (in shares) 1,660 1,645